Life Sciences
The collaboration aims to lower the cost of prescription drugs for Capital Blue Cross members.
The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.
Kaleidoscope, Surge, Optellum, Cionic and Arcascope also announce funding rounds.
Mati Gil, CEO of AION Labs, describes how its new startup OMEC.AI came to fruition and what it aims to accomplish for drug discovery and development.
Device Connect for Fitbit aims to help healthcare and life science organizations use and analyze data from Fitbit's health-tracking wearables.
nference said researchers can use the de-identified clinical data to develop new therapeutics and diagnostics.
A review of studies published in npj Digital Medicine found digital and face-to-face CBT show similar effectiveness for treating depression.
Smart stethoscope company Eko received a $2.7 million grant from the National Institutes of Health, and Halo raised $2.6 million for its research and development collaboration tool.
The company announced a $200 million Series C round in January.
Alphabet's life science arm also announces the company's founder Andy Conrad will step down as CEO. Current president Stephen Gillett will take on the role in January.